New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA-Reference-Cited by-同舟云学术

New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA

Published:2003-06 Issue:3 Volume:145 Page:349-358
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Haj Hayet Tayeb-Bel,Salerno Milena,Priebe Waldemar,Kozlowski Henryk,Garnier-Suillerot Arlette

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference23 articles.

1. Association of anthracycline derivatives with DNA: a fluorescence study;Valentini;Il Farmaco,1985

2. Mechanism of action-governed design of anthracycline antibiotics: turn-off/turn-on approach;Priebe;Curr. Pharm. Des.,1995

3. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG);Gao;Anti-Cancer Drug Des.,1991

4. The interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 12 A resolution;Wang;Biochemistry,1987

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin;Biomolecules;2022-11-03

2. Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin;ACS Applied Materials & Interfaces;2020-11-16

3. A liquid biopsy-guided drug release system for cancer theranostics: integrating rapid circulating tumor cell detection and precision tumor therapy;Lab on a Chip;2020

4. ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells;Journal of Biosciences;2019-04-09

5. 1,3-dimethyl-6-nitroacridine derivatives induce apoptosis in human breast cancer cells by targeting DNA;Drug Development and Industrial Pharmacy;2018-11-04